Feed / AVTR

Avantor, Inc.

AVTR

Healthcare · 14.91 +0.2% today

Isolated · not yet confirmedMarket checked 10 Sept, 16:00 GMT-4

Market read

Avantor, Inc.'s current read is isolated; its market group is not confirming.

The latest filing evidence is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.

What changed
  • Operating margin fell 3.0 percentage points.
Company+0.2% todayVolume comparison unavailable
Market group0 of 1 activeMedical Instruments & Supplies · unavailable
Disclosed network0 of 2 confirmingNo filing-linked name is confirming now
What would change this read
  • Gross margin contracted 170 basis points for the six months ended June 30, 2026, driven by unfavorable product mix, inflationary pressures, higher inventory reserves and freight costs.

Invalidation: The isolated read changes if AVTR's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Healthcare · Medical Instruments & Supplies

The latest filing evidence is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges
  • Operating margin fell 3.0 percentage points.
  • Net income decreased 32.9% versus the comparable filing period.
  • Gross margin fell 2.2 percentage points.
What would clarify the read
  • Gross margin contracted 170 basis points for the six months ended June 30, 2026, driven by unfavorable product mix, inflationary pressures, higher inventory reserves and freight costs.

Company research

Understand the business, not just the ticker

As of Sep 11, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods9
Price observations327
Usable filing statements137
Verified relationships3
Evidence supporting the case

No qualifying supportive evidence was identified.

Evidence challenging the case
  • Latest annual revenue changed -3.4% year over year.
  • Operating margin changed -19.7 percentage points in the latest annual period.
  • Net margin changed -18.6 percentage points in the latest annual period.
  • Credit and interest rates has repeated adverse evidence across 5 filings.
  • Macroeconomic conditions has repeated adverse evidence across 5 filings.
  • Restructuring and cost reductions has repeated adverse evidence across 5 filings.
  • Capital investment and capacity has repeated adverse evidence across 4 filings.
  • Input and raw-material costs has repeated adverse evidence across 4 filings.
Questions before a position

No credible peer-relative valuation comparison is available yet.

Longer-term price context

Price as of Sep 10, 2026

14.91
6m+79.8%12m+16.2%24m
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$7.4B+15.5%$0.85+2.8%
2022-12-31$7.5B+1.7%$1.01+13.3%
2023-12-31$7.0B-7.3%$0.47-0.1%
2024-12-31$6.8B-2.6%$1.04+0.5%
2025-12-31$6.6B-3.4%$-0.78-0.2%

What management says matters

Persistent and emerging business drivers

Credit and interest ratesnegative · 5 filings
Net income for the six months ended June 30, 2026 decreased primarily due to lower operating income, as previously discussed, and higher income tax expense, partially offset by the absence of pension termination charges incurred in the prior year and lower in…
10-Q · Jul 29, 2026
Macroeconomic conditionsnegative · 5 filings
The decrease was primarily driven by unfavorable product mix and inflationary pressures on SG&A expenses.
10-Q · Jul 29, 2026
Restructuring and cost reductionsnegative · 5 filings
No goodwill impairment was identified as a result of the reorganization, and the total carrying value of goodwill was unchanged.
10-Q · Jul 29, 2026
Capital investment and capacitynegative · 4 filings
These valuation methods require management to make numerous assumptions, including but not limited to future profitability and cash flows, net sales, gross margin, SG&A expenses, capital expenditures, investments in debt‑free net working capital, discount rat…
10-Q · Jul 29, 2026

Valuation discipline

Peer-relative valuation withheld

Jodie found no industry-matched filing peers suitable for a valuation comparison. It will not substitute broader financial-sector names.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

14.91+0.2% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 10 Sept, 16:00 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for AVTR. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Latest filing assessment · baseline

The latest filing shows material pressure

10-Q filed 2026-04-29 against the comparable filing from 2025-04-25.

cautious
OperationscautiousEvidence score -2
liquidityneutralEvidence score 0
valuationdiscount

What improved

No thresholded improvement was identified.

What weakened

  • Operating margin fell 3.0 percentage points.
  • Net income decreased 32.9% versus the comparable filing period.
  • Gross margin fell 2.2 percentage points.

Filing receipts

Net income (in millions) Three months ended March 31, Change 2026 2025 Operating income $ 99.5 $ 147.4 $ (47.9) Interest expense, net (42.9) (42.2) (0.7) Loss on extinguishment of debt (0.6) — (0.6) Other expense, net (0.5) (19.5) 19.0 Income tax expense (12.2) (21.2) 9.0 Net income $ 43.3 $ 64.5 $ (21.2) Three months ended Net income for the three months ended March 31, 2026 decreased primarily due to lower operating income, as previously discussed, partially offset by the absence of pension termination charges incurred in the prior year and lower income tax expense from reduced taxable income.

The decrease was primarily due to lower sales volume, higher inventory reserves, unfavorable product mix and inflationary pressures on compensation expense.

These valuation methods require management to make numerous assumptions, including but not limited to future profitability and cash flows, net sales, gross margin, SG&A expenses, capital expenditures, investments in debt‑free net working capital, discount rates reflecting current market assumptions, the weighting of valuation methods, and the selection of comparable publicly traded companies.

Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.

Business ecosystem

The relationships behind AVTR

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depended on by

ESTAEstablishment Labs Holdings Inc.supplierFeb 27, 2026

In particular, we obtain NuSil brand medical-grade silicone from Avantor, Inc.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 1 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

AVTR is currently a Leader in the organic co-movement group Medical Instruments & Supplies. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for AVTR; it is not active in the latest market snapshot.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.